Application of LC-MS/MS Method for Evaluating Rosuvastatin Affinity with OATP1B1 and OATP2B1 in vitro

被引:1
|
作者
Zhang, Zhi-Yu [1 ,2 ]
Li, Quan-Sheng [2 ]
Si, Duan-Yun [2 ]
Yi, Xiu-Lin [2 ]
Liu, Chang-Xiao [2 ]
机构
[1] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China
[2] Tianjin Inst Pharmaceut Res, State Key Lab Drug Delivery Technol & Pharmacokin, Tianjin 300193, Peoples R China
关键词
LC/MS/MS; Transporter; Rosuvastatin; OATP1B1; OATP2B1; HUMAN PLASMA; MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; HEPATIC-UPTAKE; TRANSPORTERS; QUANTIFICATION; DRUG; PHARMACOKINETICS; ACID; HPLC;
D O I
10.14233/ajchem.2014.15376
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Drug-drug interaction is one of the Most important preclinical investigation directions, It may have serious impact on drug absorption, distribution and elimination through Membrane transporters, Liquid chromatography/Tandem Mass spectrometry (LC/MS/MS) Could be used to investigate drug drug interaction in vitro. A sensitive LC/MS/MS method was established for quantification of rosuvastatin in HEK293 and S2 cell lysates. Internal standard (IS) was indapamide. Detection mode was positive eleetrospray ionization. The lower limit of quantification (LLOQ) was 0.05 ng/mL. The affinity of rosuvastatin with organic anion transporting polypeptides 1B1 and 2B1 (OATP1B1 and OATP2B1) was investigated through uptake experiment, All cell samples were precipitated with methanol. Analytes were separated by reversed-phase chromatography and analyze by Tandem mass spectrometry using m/z 482.2/258.1 for rosuvastatin and m/z 366.1/132.1 for indapamide. Rosuvastatin uptake was saturable with KM value of 11.70 and 5.98 mu M for OATP1B1 and OATP2B1. Rosuvastatin could be used as a good probe for studying membrane transporter activity and drug-drug interaction through LC/MS/MS method.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 50 条
  • [21] COMPREHENSIVE ANALYSIS OF GENETIC AND NON-GENETIC FACTORS AFFECTING EXPRESSION OF THE ORGANIC ANION TRANSPORTERS OATP1B1, OATP1B3, AND OATP2B1 IN HUMAN LIVER
    Nies, Anne T.
    Winter, Stefan
    Burk, Oliver
    Klein, Kathrin
    Zanger, Ulrich M.
    Stieger, Bruno
    Schwab, Matthias
    Schaeffeler, Elke
    HEPATOLOGY, 2010, 52 (04) : 433A - 433A
  • [22] Specific and general inhibitors of the three hepatic organic anion transporters OATP1B1 (SLCO1B1), OATP1B3 (SLCO1B3) and OATP2B1 (SLCO2B1)
    Karlgren, Maria
    Ahlin, Gustav
    Vildhede, Anna
    Artursson, Per
    DRUG METABOLISM REVIEWS, 2010, 42 : 305 - 306
  • [23] Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans
    Hirano, M
    Maeda, K
    Shitara, Y
    Sugiyama, Y
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (01): : 139 - 146
  • [24] Digoxin is not a substrate for organic anion transporting polypeptide transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but is a substrate for a sodium dependent transporter expressed in HEK293 cells
    Taub, Mitchell E.
    Mease, Kirsten
    Sane, Rucha S.
    Watson, Cory A.
    Chen, Liangfu
    Ellens, Harma
    Hirakawa, Brad
    Reyner, Eric L.
    Jani, Marton
    Lee, Caroline A.
    DRUG METABOLISM REVIEWS, 2011, 43 : 195 - 196
  • [25] Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3
    Noe, Johannes
    Portmann, Renee
    Brun, Marie-Elise
    Funk, Christoph
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (08) : 1308 - 1314
  • [26] Establishing the Competitive Counterflow Assay for OATP1B1 and OATP1B3
    Katuwal, Miki
    Schnegelberger, Regina
    Wityk, Elliott
    Ruggiero, Melissa
    Hagenbuch, Bruno
    FASEB JOURNAL, 2016, 30
  • [27] Structure of human drug transporters OATP1B1 and OATP1B3
    Ciuta, Anca-Denise
    Nosol, Kamil
    Kowal, Julia
    Mukherjee, Somnath
    Ramirez, Ana S.
    Stieger, Bruno
    Kossiakoff, Anthony A.
    Locher, Kaspar P.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [28] Structure of human drug transporters OATP1B1 and OATP1B3
    Anca-Denise Ciută
    Kamil Nosol
    Julia Kowal
    Somnath Mukherjee
    Ana S. Ramírez
    Bruno Stieger
    Anthony A. Kossiakoff
    Kaspar P. Locher
    Nature Communications, 14
  • [29] Functional impact of SNPs in OATP1B1 on rosuvastatin uptake in Xenopus oocytes
    Brown, CD
    Gray, PA
    Wang, Y
    Windass, AS
    FASEB JOURNAL, 2005, 19 (05): : A1608 - A1608
  • [30] Is Ethnic Variability in the Exposure to Rosuvastatin Explained Only by Genetic Polymorphisms in OATP1B1 and BCRP or Should the Contribution of Intrinsic Ethnic Differences in OATP1B1 Be Considered?
    Sugiyama, Yuichi
    Maeda, Kazuya
    Toshimoto, Kota
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (09) : 2227 - 2230